AWC
CRSP icon

Abundance Wealth Counselors’s CRISPR Therapeutics CRSP Stock Holding History

Abundance Wealth Counselors’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
+5,015
New +$264K 0.02% 242
2025
Q4 		– Sell
-3,303
Closed -$214K – 167
2025
Q3 		$214K Buy
+3,303
New +$190K 0.04% 157
2021
Q2 		– Sell
-215
Closed -$26K – 155
2021
Q1 		$26K Buy
+215
New +$32.5K 0.01% 208

Other funds holding CRSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Abundance Wealth Counselors's CRSP Position: Q2 2026 in Review

Abundance Wealth Counselors opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 5,015 shares worth $274K. The stake represents 0.02% of the portfolio and ranks #242 among its holdings. This is a return to the name: Abundance Wealth Counselors previously reported a position in CRSP as recently as Q3 2025.

Abundance Wealth Counselors first reported a position in CRSP in Q1 2021 and has held it in 3 quarters since. 271 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Abundance Wealth Counselors held 5,015 shares of CRISPR Therapeutics worth $274K as of Q2 2026.
  • CRISPR Therapeutics was a new Abundance Wealth Counselors position in Q2 2026.
  • CRISPR Therapeutics made up 0.02% of Abundance Wealth Counselors's portfolio in Q2 2026, its #242 holding.
  • Abundance Wealth Counselors first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 3 quarters since.
  • 271 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.